Alzheimer's Disease and Cancer: Common Targets

Area of Science:

• Oncology
• Neuroscience
• Molecular Biology

Background:

• Growing evidence suggests an inverse association between cancer and Alzheimer's disease (AD).
• Shared signaling pathways regulate both cell survival and death, implicating their dysregulation in both cancer and AD pathogenesis.
• A common molecular basis between cancer and AD is increasingly recognized.

Purpose of the Study:

• To review the role of specific molecular targets in the pathogenesis of cancer and AD.
• To discuss the current status of drug development targeting these shared pathways.

Main Methods:

• Literature review of studies investigating molecular mechanisms in cancer and AD.
• Analysis of the roles of Glycogen Synthase Kinase 3 (GSK3), Death-Associated Protein Kinase 1 (DAPK1), Protein Phosphatase 2A (PP2A), Tumor Protein P53 (P53), and Cannabinoid Receptor 2 (CB2R).

Main Results:

• GSK3, DAPK1, PP2A, P53, and CB2R are implicated in the shared molecular pathways of cancer and AD.
• These targets represent potential points for therapeutic intervention in both diseases.

Conclusions:

• The identified molecular targets (GSK3, DAPK1, PP2A, P53, CB2R) offer promising avenues for developing drugs with dual efficacy against cancer and AD.
• Further research into these common mechanisms could lead to novel therapeutic strategies for these complex diseases.